Corbus Pharmaceuticals Holdings Stock Forecast
Corbus Pharmaceuticals Holdings stock upgraded from Strong Sell Candidate to Sell Candidate after Thursday trading session.
(Updated on Apr 18, 2024)
The Corbus Pharmaceuticals Holdings stock price fell by -1.70% on the last day (Thursday, 18th Apr 2024) from $37.16 to $36.53. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.15% from a day low at $35.26 to a day high of $37.78. The price has risen in 6 of the last 10 days but is still down by -6.26% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -290 thousand shares and in total, 128 thousand shares were bought and sold for approximately $4.67 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $34.67 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 94.90% during the next 3 months and, with a 90% probability hold a price between $67.58 and $114.18 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CRBP Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Corbus Pharmaceuticals Holdings stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $39.50 and $38.99. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -22.41%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Corbus Pharmaceuticals Holdings stock
On the downside, the stock finds support just below today's level from accumulated volume at $30.90 and $29.49. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Corbus Pharmaceuticals Holdings finds support just below today's level at $30.90. If this is broken, then the next support from accumulated volume will be at $29.49 and $27.79.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.52 between high and low, or 7.15%. For the last week, the stock has had daily average volatility of 8.83%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CRBP) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Corbus Pharmaceuticals Holdings to open at $36.52, and during the day (based on 14 day Average True Range), to move between $32.80 and $40.26, which gives a possible trading interval of +/-$3.73 (+/-10.22%) up or down from last closing price. If Corbus Pharmaceuticals Holdings takes out the full calculated possible swing range there will be an estimated 20.43% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $40.32 (10.38%) than the support at $30.90 (15.41%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Corbus Pharmaceuticals Holdings stock A Buy?
The Corbus Pharmaceuticals Holdings stock holds several negative signals and despite the positive trend, we believe Corbus Pharmaceuticals Holdings will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -3.914 Sell Candidate Upgraded
Predicted Opening Price for Corbus Pharmaceuticals Holdings of Friday, April 19, 2024
Fair opening price April 19, 2024 | Current price |
---|---|
$36.52 ( 0.0182%) | $36.53 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CRBP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 39.04 | 6.88 % | |
R2 | 38.08 | 4.24 % | ||
R1 | 37.49 | 2.62 % | ||
Current price: | 36.53 | |||
Support | S1 | 35.56 | -2.65 % | |
S2 | 34.97 | -4.28 % | ||
S3 | 34.00 | -6.92 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 44.93 | 22.99 % | |
R2 | 43.68 | 19.57 % | ||
R1 | 40.32 | 10.38 % | ||
Current price | 36.53 | |||
Support | S1 | 30.90 | -15.41% | |
S2 | 29.49 | -19.27% | ||
S3 | 27.79 | -23.93% |
FAQ
Click here for our free guide on how to buy Corbus Pharmaceuticals Holdings Stock.